Biotech Acquisition Co (Biotech Acquisition Co) EBITDA Margin % : 0.00% (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Biotech Acquisition Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Biotech Acquisition Co's EBITDA for the three months ended in Sep. 2022 was $-0.25 Mil. Biotech Acquisition Co's Revenue for the three months ended in Sep. 2022 was $0.00 Mil. Therefore, Biotech Acquisition Co's EBITDA margin for the quarter that ended in Sep. 2022 was 0.00%.

Biotech Acquisition Co EBITDA Margin % Historical Data

The historical data trend for Biotech Acquisition Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotech Acquisition Co EBITDA Margin % Chart

Biotech Acquisition Co Annual Data

Trend

Dec20

Dec21

EBITDA Margin %

Biotech Acquisition Co Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
EBITDA Margin %	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Biotech Acquisition Co's EBITDA Margin %

For the Shell Companies subindustry, Biotech Acquisition Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotech Acquisition Co's EBITDA Margin % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Biotech Acquisition Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Biotech Acquisition Co's EBITDA Margin % falls into.

Biotech Acquisition Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Biotech Acquisition Co's EBITDA Margin % for the fiscal year that ended in Dec. 2021 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2021 )	/	Revenue (A: Dec. 2021 )
	=	-1.57	/	0
	=	%

Biotech Acquisition Co's EBITDA Margin % for the quarter that ended in Sep. 2022 is calculated as

EBITDA Margin %	=	EBITDA (Q: Sep. 2022 )	/	Revenue (Q: Sep. 2022 )
	=	-0.247	/	0
	=	%

Biotech Acquisition Co (NAS:BIOT) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Biotech Acquisition Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Biotech Acquisition Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotech Acquisition Co (Biotech Acquisition Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Biotech Acquisition Co (NAS:BIOT) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

545 West 25th Street, 20th Floor, New York, NY, USA, 10001

Website

Biotech Acquisition Co is a blank check company.

Executives

Albert F Hummel	director, officer: Chief Investment Officer	PO BOX 3407, RANCHO SANTA FE CA 92067
Biotech Sponsor Llc	10 percent owner	545 W. 25TH ST., 20TH FLOOR, NEW YORK NY 10001
Bruno Montanari	director	545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001
Ivan Jarry	officer: Chief Operating Officer	545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001
Paul Bernard	director	545 WEST 25TH STREET 20TH FL, NEW YORK NY 10001
Aaron Kim	director	545 WEST 25TH STREET 20TH FL, NEW YORK NY 10001
Michael Schleifer	director, 10 percent owner, officer: Chief Executive Officer	545 WEST 25TH STREET 20TH FLOOR, NEW YORK NY 10001
Thomas Fratacci	officer: CFO & Treasurer	545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001